Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corp (BCPC) delivers specialty performance ingredients for nutrition and industrial markets through advanced technologies. This news hub provides investors and industry professionals with essential updates on corporate developments and market leadership.
Access authoritative reporting on earnings announcements, product innovations, and strategic partnerships. Our curated collection ensures you stay informed about BCPC's advancements in microencapsulation techniques and chelation technology across human/animal nutrition sectors.
Discover press releases detailing regulatory milestones, manufacturing expansions, and sustainability initiatives. All content is verified for accuracy, offering neutral analysis without speculative commentary.
Bookmark this page for real-time access to Balchem's financial disclosures and operational updates. Regularly refreshed content supports informed decision-making for stakeholders tracking specialty chemical markets.
Balchem Corporation (NASDAQ: BCPC) announced a dividend of $0.58 per share on December 16, 2020, marking an 11.5% increase from last year. This dividend will be payable on January 22, 2021, to stockholders of record on December 28, 2020. This represents the eleventh consecutive increase in their annual dividend, reflecting the company’s strong financial performance and the Board's confidence in future strategies, according to CEO Ted Harris.
Balchem Corporation (NASDAQ: BCPC) will present at the Stephens Annual Investment Conference 2020 on November 17, 2020, at 2:00 p.m. (EST). The presentation will be led by Chairman and CEO Ted Harris, along with CFO Martin Bengtsson. Interested parties can access presentation materials before the conference via Balchem's investor relations website.
Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries, including Human Nutrition, Animal Nutrition, and Specialty Products.
Balchem Corporation will present at Baird’s 2020 Global Industrial Conference on November 12, 2020. The presentation, featuring CEO Ted Harris and CFO Martin Bengtsson, is scheduled for 12:50 p.m. EST. Attendees can access presentation materials in advance via the official website.
Balchem Corporation (NASDAQ: BCPC) reported record third quarter net earnings of $21.6 million for 2020, marking a 4.3% increase from 2019. Net sales rose by 10.4% to $175.1 million, driven by growth in Human and Animal Nutrition sectors. Adjusted net earnings reached $26.9 million, up 2.3% year-over-year, with adjusted EBITDA at $44.4 million, a 10.1% increase. Cash flows from operations were $35.4 million and free cash flow was $28.3 million. The company's net debt decreased to $114.6 million. Balchem continues to implement its ERP system and advances its ESG commitments.
Balchem Corporation (NASDAQ: BCPC) announced a conference call scheduled for October 28, 2020, at 11:00 AM ET to discuss its third-quarter results, which will be published before market opening on the same day. The call will be hosted by CEO Ted Harris and CFO Martin Bengtsson, with a replay available until November 11, 2020. The company, known for enhancing health through its specialty ingredients across various sectors, operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will present at Morningstar's Management Behind the Moat Conference on September 29, 2020, at 9:00 a.m. EDT. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Interested parties can access the presentation materials prior to the event at here.
Balchem focuses on specialty ingredients within three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will present at the Sidoti Fall 2020 Virtual Investor Conference on September 23, 2020, starting at 2:30 p.m. EDT. The presentation will be led by CEO Ted Harris and CFO Martin Bengtsson. Investors can access a live webcast of the event through a specified link, with a replay available approximately 24 hours later until December 23, 2020.
Balchem specializes in developing and marketing ingredients for health and well-being across various industries, with segments in Human Nutrition, Animal Nutrition, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) reported a record net earnings of $21.1 million for Q2 2020, reflecting an increase from $19.8 million in Q2 2019. Adjusted net earnings rose to $27.6 million, up 9.2% year-over-year. Net sales reached $173.4 million, a 7.3% increase compared to the previous year. The company's adjusted EBITDA also hit a record $43.9 million, marking a 9.8% growth. Strong cash flow allowed for $35.0 million in debt repayment, reducing net debt to $142.2 million.
FAQ
What is the current stock price of Balchem (BCPC)?
What is the market cap of Balchem (BCPC)?
